← Open Payments lookup

ZACHARY MATHEWS: Open Payments

NPI 1457048472 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,762 in 143 payments from 18 companies in 2025. Trend: 2023 $1,717 · 2024 $2,336 · 2025 $2,762

Food & beverage: $2,762
CompanyPaymentsAmount
ABBVIE INC.40$572
AstraZeneca Pharmaceuticals LP25$538
Novo Nordisk Inc9$219
Amgen Inc.10$209
PFIZER INC.11$162
Bayer Healthcare Pharmaceuticals Inc.6$135
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$122
Boehringer Ingelheim Pharmaceuticals, Inc.5$109
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$99
Novartis Pharmaceuticals Corporation4$93

Products named: AIRSUPRA, UBRELVY, VRAYLAR, QULIPTA, BREZTRI, Kerendia, CAPLYTA, NURTEC ODT.

Industry payments across MD — which companies pay providers there.